Tag: United States
PhRMA Membership Dues Drop by Nearly $100 Million due to Major Drugmakers Exiting
PhRMA Membership Dues Plummet by $100 Million After Major Drugmakers ExitIn a significant blow to the Pharmaceutical Research and Manufacturers of America (PhRMA), three major pharmaceutical companies, AbbVie, AstraZeneca, and Teva, made the decision...
RFK Jr. as HHS Secretary: Scientists’ Opinions and Analysis
President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This decision has sparked controversy, as RFK Jr. is known for being a vaccine skeptic. The...
Supreme Court hesitates on trans care bans: Conservative-led judiciary cautious
Supreme Court Hesitates on Trans Care Bans: Conservative-Led Judiciary CautiousConservative Supreme Court justices appeared skeptical Wednesday of arguments that they should intervene in Tennessee’s ban on gender-affirming care for minors. The court heard arguments...
USDA National Milk Testing Program to Track H5N1 Flu Outbreak in Cows
USDA to Implement National Milk Testing Program to Combat H5N1 Flu Outbreak in CowsIn response to the alarming spread of the H5N1 bird flu among dairy cows in California, the U.S. Department of Agriculture...
Eli Lilly to Test Obesity Medications for Alcohol and Drug Addiction: CEO Announces Study
Eli Lilly Breaks New Ground in Addiction Treatment ResearchEli Lilly, the pharmaceutical giant behind the popular weight loss drug Zepbound, has made a groundbreaking announcement. The company is set to embark on a study...
Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions
Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
Navigating the Latest Changes in the Industry: Up and Down the Career Ladder
Exciting Changes in the Pharmaceutical IndustryLipigon Pharmaceuticals, a leading player in the pharmaceutical industry, has recently made a significant change at the top with the appointment of Johan Liwing as their new chief executive...
Understanding Palliative Care: Insights from a Professional | NIH MedlinePlus Magazine
Understanding Palliative Care: A Compassionate GuideIn the realm of healthcare, when serious or terminal illnesses strike, patients and their families are often left grappling with difficult decisions and overwhelming emotions. The vast array of...
Advancements in Sanofi’s Treatment for Rare Platelet-Destroying Disease
Sanofi's Breakthrough Treatment for Rare Platelet-Destroying Disease
The annual meeting of the American Society of Hematology showcased exciting developments in the treatment of a rare autoimmune disorder called immune thrombocytopenia (ITP). Sanofi, a French pharma...
Bestselling Bed Sheets Loved by Readers: Top Picks and Reviews
Although many may not give much thought to the sheets they sleep on, the reality is that quality bedding can make a significant difference in your sleep experience. From luxurious bamboo options to cooling...
Simplified Heart Failure Risk Estimation Model for Cost-Effective Analysis
Revolutionizing Heart Failure Risk Estimation
In a groundbreaking development, the American Heart Association introduced the PREVENT calculator, a transformative tool that redefines cardiovascular risk assessment. Released just over a year ago, this innovative model represents...
